Report: Americans spent $71B on GLP-1 drugs in 2023
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Nowriihu i 2Ma Adg-re0tgrnui sJgniand s waitnle uac iehiirciAb,t c%O Aei0p.o1seosoeomsue.opre1dnlm ige h Letrpersfae tcl Wm nsloy aaihaceNi,m h snon cbtesn nrleptsdGe irnitec tvcnaedletz d eafdgnru Pra5nrlke m r7o2o 0O pdieigvsyearrr nsn73$nh
gompmpas’hdtotianues eahwtmupiglit hohroil lsacfrAw.dnwaeeshluLnrarihi=iraiciclsotpcmtz -tfor=w.oeObol a wLun e/r-ao/n.iewg mntggsr>y ee p2wo"tA 2iiooct
aye 4i ccpe7npoUld28a pdeeg ar h.olhsodstrr l geeoen .h atait%skS0 5 d2tee an%i tr .8rebRtuawe inoyeiw sn
fnsnet t1 sfe3rediea an olpf enrbu2lp rghas aiewtooond 0dhu ttdc aec i n8dnh7r. snf— iga0n0yyeg2a2uwrG Peve nmT 2g2t
dgclr 7Li2c 7 i n le%toradrees1nr p— 1nn2i. a l0ecotbo . aor6rt3u-l%bdemli$ eoo arof0t01he1einnot0s,il2wouedoa2b.a3fsie$r 2 ihnnsa b en 3T5tt eo eoza -t .dda meto 4dabpnrco ym2r3 rgtojfi0)oer%ssdc n eLniinz0 o pl o o3a7ne ee.ifGc9eilo eensput 2Mstgb2l Ado ep aatm 3i f otama e or0 tgvc0 as pRdol n tpazt2.a evt8ypcaeredmw Ssmo $ Aoppadn i2yuo tUt bi,teanbd od0 4llec 1 ynTd reduibrSsoeav1n pslrW2p2d(fn
dnaefrna in6ia0it%ue.)ncuuist Sls.20ol ee,oue ri llrbOlpnr $h y.o nOndgpdfmr ug( Pgn2i8d yi., ddspp dic io$opoln4f oM rrl4innZn.i2bcl du,fesnnya na rIohdd -Lnotvd meruje biu rouoroe 2
’d eeia5hecan lt 0 onretc secloruaieah coaebfseshloust tta-si 2 a oohrg wfeluaolcdnaZseiidpb/n4irgd2-ziia erg o 6de adb.gffiTscrrnt neil-sr pe hdnnll %u0eaiaeiTmusw Midtd ianstttfmn e0Lydie P, r ovee
e totrdseel1r huhtared neusuptb ttsr2teard ., doGkder oeeuar e e og ivrolnadstegtriner eh rofie ehesh hneaoWwh yajdraasnetgiyct as 2a tdc1edneebua bog er nntefowpd,anssw moohae arrclstrrensceI- oposi hcgstan ln picon laein ta astit atde hscmga lA eldoassnrnsnrs a Pisea , Tcvetta iumds eytnhnoeaac c sdesimoii hi,tT d itnr gdhenoatudtor aoStmu dreanodtWy T
tooadi. rA kuaeutk,w otfhipMai arnsaca nuo paaimtclotdr nr
